Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Below-the-Table System May Protect Against Scatter Radiation in the Cath Lab

Yael L. Maxwell

May 25, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

Michael O'Riordan

May 21, 2018

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

Presentation EuroPCR 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presenter: Ulrich Gerckens

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Conference News EuroPCR 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

Advertisement

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Below-the-Table System May Protect Against Scatter Radiation in the Cath Lab

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content